Argentis taking steps toward FDA review (BizJournals)
Argentis Pharmaceuticals LLC has selected Target Health Inc. for its upcoming clinical trials, which brings the Memphis startup one step closer to FDA review.

Akorn Announces Development and Supply Agreement with Hyaluron For Two Injectable ANDA Suspension Drug Products (Business Wire via Yahoo! Finance)
BUFFALO GROVE, Ill.----Akorn, Inc. today announced the signing of a development and supply agreement with Hyaluron Contract Manufacturing, Inc. , an innovative leader in aseptic formulation and filling of liquid parenterals located in Burlington, Massachusetts.